1921
Volume 81, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Chronic liver infection and cancer in the western Pacific region is disproportionate to the population globally. This study provides the first nationwide estimates of hepatitis B surface antigen (HBsAg) seroprevalence in Cambodia among children five year of age. Using a simple and rapid test for HBsAg and multi-stage stratified cluster sampling design, we estimated HBsAg seroprevalence to be 3.5% (95% confidence interval = 2.4–4.8%) among five-year old children. Triangulating the results with other studies, we demonstrate the importance of interrupting perinatal transmission and one-time catch-up vaccination of older children born before nationwide introduction of vaccination for effective hepatitis B control in Cambodia and for reaching the disease control goal of less than 2% chronic infection rates among children ≥ 5 years of age. The results demonstrate the feasibility of conducting nationwide serosurveys using simple and rapid tests to evaluate the impact of hepatitis B vaccination programs in lieu of standard enzyme-linked immunosorbent assays.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2009.81.252
2009-08-01
2017-11-19
Loading full text...

Full text loading...

/deliver/fulltext/14761645/81/2/0810252.html?itemId=/content/journals/10.4269/ajtmh.2009.81.252&mimeType=html&fmt=ahah

References

  1. Clements CJ, Baoping Y, Crouch A, Hipgrave D, Mansoor O, Nelson CB, Treleaven S, Konkelenberg RV, Wiersma S, 2006. Progress in the control of hepatitis B infection in the Western Pacific Region. Vaccine 24 : 1975–1982.
  2. Gust ID, 1996. Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Gut 38 : 18–23.
  3. World Bank, 2007. World Bank Development Indicators Database. Available at: http://siteresources.worldbank.org/DATA-STATISTICS/Resources/GNIPC.pdf. Accessed September 16, 2008.
  4. Snitbhan R, Scott R, Bancroft WH, Top FH Jr, Chiewsilp D, 1975. Subtypes of hepatitis B surface antigen in south-east Asia. J Infect Dis 131 : 708–711.
  5. Thuring EG, Joller-Jemelka HI, Sareth H, Sokhan U, Reth C, Grob P, 1993. Prevalence of markers of hepatitis viruses A, B, C and of HIV in healthy individuals and patients of a Cambodian province. Southeast Asian J Trop Med Public Health 24 : 239–249.
  6. Caruana SR, Kelly HA, De Silva SL, Chea L, Nuon S, Saykao P, Bak N, Biggs BA, 2005. Knowledge about hepatitis and previous exposure to hepatitis viruses in immigrants and refugees from Mekong Region. Aust N Z J Public Health 29 : 64–68.
  7. Catanzaro A, Moser RJ, 1982. Health Status of refugees from Vietnam, Laos and Cambodia. JAMA 247 : 1303–1308.
  8. Yao GB, 1996. Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China. Gut 38 : 39–42.
  9. Hipgrave DB, Nguyen TV, Vu MH, Hoang TL, Do TD, Trung NT, Jolley D, Maynard JE, Biggs BA, 2003. Hepatitis B infection in rural Vietnam and the implications for a national program of infant immunization. Am J Trop Med Hyg 69 : 288–294.
  10. Liang XF, Chen YS, Wang XJ, He X, Chen LJ, Wang J, Lin CY, Bai HQ, Yan J, Cui G, Yu JJ, 2005. A study of seroepidemiology of hepatitis B in Chinese population aged over 3-years old: the report from Chinese Center for Disease Control and Prevention. Chin J of Epidemiol 26 : 655–658.
  11. Lien TX, Tien NT, Chanpong GF, Cao TC, Vii TY, Soderquist R, Laras K, Corwin A, 2000. Evaluation of rapid diagnostic tests for the detection of human immunodeficiency virus types 1 and 2, hepatitis b surface antigen, and syphilis in Ho Chi Minh city, Vietnam. Am J Trop Med Hyg 62 : 301–309.
  12. World Health Organization, 2001. Hepatitis B Surface Antigen Assays: Operational Characteristics (Phase I). Report 1. Blood Safety and Clinical Technology. Geneva: World Health Organization, WHO/BCT/BTS/01.4.
  13. World Health Organization, 2004. Hepatitis B Surface Antigen Assays: Operational Characteristics (Phase I). Report 2. Blood Safety and Clinical Technology. Geneva: World Health Organization, WHO/BCT/BTS/01.4.
  14. Vong S, Perz JF, Sok S, Som S, Goldstein S, Hutin Y, Tulloch J, 2005. Rapid assessment of injection practices in Cambodia, 2002. BMC Public Health 5 : 56–62.
  15. James L, Fong CW, Foong BH, Wee MK, Chow A, Shim E, Chew SK, 2001. Hepatitis B seroprevalence study 1999. Singapore Med J 42 : 420–424.
  16. Ng KP, Saw TL, Baki A, Rozainah K, Pang KW, Ramanathan M, 2005. Impact of the expanded program on immunization against hepatitis B infection in school children in Malaysia. Med Microbiol Immunol (Berl) 194 : 163–168.
  17. National Institute of Public Health, National Institute of Statistics (Cambodia) and ORC Macro, 2006. Cambodia Demographic and Health Survey 2005. Phnom Penh, Cambodia and Calverton, Maryland: National Institute of Public Health, National Institute of Statistics and ORC Macro.
  18. Davaalkham D, Ojima T, Uehara R, Watanabe M, Oki I, Wiersma S, Nyamadawa P, Nakamura Y, 2007. Impact of the universal hepatitis B immunization program in Mongolia: achievements and challenges. J Epidemiol 17 : 69–75.
  19. Edstam JS, Dulmaa N, Nymadawa P, Rinchin A, Kimball AM, 2002. Comparison of hepatitis B vaccine coverage and effectiveness among urban and rural Mongolian 2-year olds. Prev Med 34 : 207–214.
  20. Edstam JS, Dulmaa N, Tsendjav O, Dambasuren B, Densmaa B, 2004. Exposure of hepatitis B vaccine to freezing temperatures during transport to rural health centers in Mongolia. Prev Med 39 : 384–388.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2009.81.252
Loading
/content/journals/10.4269/ajtmh.2009.81.252
Loading

Data & Media loading...

  • Received : 18 Sep 2008
  • Accepted : 24 Mar 2009

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error